Joshua S. Boger has seen considerable growth in his stock holdings since his time at Vertex. Initially, he held a substantial number of shares, and by 2024, those had grown in value to over $156 million. His holdings reflect not...

Stock Sold

$153.75M

VRTX

$153.75M

1,569,375 shares

What if they kept their stock?

If Joshua S. Boger didn't sell their stock, today they would have:
Extra VRTX1,569,375 shares worth $638.91M.
This is 315.55% and $485.16M more than what they got when they sold the stock.

Recent Insider Trades

VRTX

2,188 shares

VRTX

Jun 1, 2017

Received

VRTX

$665.17K

VRTX at $83.15/share

Jan 11, 2017

Sale

VRTX

$498.94K

VRTX at $76.76/share

Jan 4, 2017

Sale

VRTX

$484.61K

VRTX at $74.56/share

Dec 29, 2016

Sale

VRTX

$487.50K

VRTX at $75.00/share

Dec 21, 2016

Sale

VRTX

$505.83K

VRTX at $77.82/share

Dec 14, 2016

Sale

VRTX

$490.34K

VRTX at $75.44/share

Dec 7, 2016

Sale

VRTX

$545.58K

VRTX at $83.94/share

Nov 30, 2016

Sale

VRTX

$559.91K

VRTX at $86.14/share

Nov 23, 2016

Sale

Charitable Transactions

VRTX

557,000 shares

VRTX

Recent Charitable Transactions

No charitable transactions found for this CEO.

Joshua S. Boger

Ex-CEO of Vertex Pharmaceuticals

JS

View Compensation History

2009 Total Compensation

$5.00M

Salary

$373.41K

Bonus

$0.00

Stock

$1.58M

Other

$3.04M